1.
The fragility of phase 3 trials supporting FDA-approved anticancer medicines: a retrospective analysis
by Del Paggio, Joseph C, MD
The lancet oncology, 2019, Vol.20 (8), p.1065-1069
2.
Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks
by Del Paggio, Joseph C, MD
The lancet oncology, 2017, Vol.18 (7), p.887-894
3.
A mitochondrial redox oxygen sensor in the pulmonary vasculature and ductus arteriosus
by Dunham-Snary, Kimberly J
Pflügers Archiv, 2015-09-23, Vol.468 (1), p.43-58
4.
A critique of the fragility index – Authors' reply
by Del Paggio, Joseph C
The lancet oncology, 2019-10, Vol.20 (10), p.e554-e554
5.
A mitochondrial redox oxygen sensor in the pulmonary vasculature and ductus arteriosus1
by Dunham-Snary, Kimberly J Kimberly J
Pflügers Archiv, 2015-09-23, Vol.468 (1), p.43-58
